The doctor's order summarizes the treatment plan for a patient over three days, beginning on June 17th. It includes referring the patient to isolation, obtaining consent, monitoring vital signs and administering IV fluids. Labs are ordered and diet is allowed as tolerated. On the 17th, chemotherapy is held for one week and new treatment is scheduled. Present management is to continue. On the 18th, the patient is to be referred accordingly and continue IV fluids, positioning, oxygen, breathing exercises and input/output monitoring.
The doctor's order summarizes the treatment plan for a patient over three days, beginning on June 17th. It includes referring the patient to isolation, obtaining consent, monitoring vital signs and administering IV fluids. Labs are ordered and diet is allowed as tolerated. On the 17th, chemotherapy is held for one week and new treatment is scheduled. Present management is to continue. On the 18th, the patient is to be referred accordingly and continue IV fluids, positioning, oxygen, breathing exercises and input/output monitoring.
The doctor's order summarizes the treatment plan for a patient over three days, beginning on June 17th. It includes referring the patient to isolation, obtaining consent, monitoring vital signs and administering IV fluids. Labs are ordered and diet is allowed as tolerated. On the 17th, chemotherapy is held for one week and new treatment is scheduled. Present management is to continue. On the 18th, the patient is to be referred accordingly and continue IV fluids, positioning, oxygen, breathing exercises and input/output monitoring.
6-17-2020 refer admit to isolation room >For Proper monitoring management and 9:00 am evaluation, Secure consent >Patient has the right to be consented in all procedures to be done. V/S q4 >To have a baseline data D5 LR IL with 30 gtts/min >to maintain fluid and electrolyte balance.
DAT >Diet as tolerated to maintain nutritional
status of patient. Labs : WBC, ANC, HgB, platelets, >It is used as a broad screening test to check bilirubin, creatinine for such disorders as anaemia, infection, and much other disease. 6-17-2020 Hold-up of treatment for 1 week >set >allow the body to take a break with all the 1:00 pm new schedule for cycle 2 to begin on medications being administered. 24 of June. Meds: Administer on June 24th the FF drugs; >maintain the cycle 2 in chemotherapy of Epirubicin 160 mg IV push the patient. Fluorouracil 800 mg IV push Cyclophosphamide 800 mg IV in 100 to 250 mL NS over 20 to 60 minutes
Continue present management
> For continues management 6-18-2020 Refer accordingly 10am For the continuity of care refer any unusualties and progress. IVF to follow D5 LR IL with 30 > to maintain fluid and electrolyte balance. gtts/min Place in moderate to high back rest >To promote lung expansion Maintain O2 >To support oxygen in the body For STAT post-op x-ray >Test that involves exposing the chest briefly to radiation to produce and image of the chest and the internal organs of the chest. Deep breathing exercises >To controlled Monitor I and O every shift >To monitor patients fluid status Place patient in semi-fowler position >To promote lung expansion Continue meds > for compliance